论文信息 - A Phase II Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive- and CD30-Positive Lymphomas - 字舞流文

A Phase II Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive- and CD30-Positive Lymphomas

Dong-Wan Kim | D. Heo | J. Lee | Y. Jeon | B. Keam | T. Kim | J. S. Lee | Jiwon Koh | Jeong-Ok Lee | Miso Kim | J. Lee | J. Lee